Julio Delgado
No Rating Available
(Learn About Our Rating System)

Julio Delgado, MD, MS

Languages spoken: Spanish, English

Clinical Locations

Primary Location

ARUP

500 Chipeta Way
Salt Lake City , UT 84108
Get Directions

  • Dr. Delgado is the Executive Vice President at ARUP Laboratories, as well as Tenure Professor and Vice Chair, Department of Pathology at University of Utah. He is board certified in Clinical Pathology and Histocompatibility Laboratory testing by the American Board of Pathology and the American Board of Histocompatibility and Immunogenetics. He received his MD degree from Universidad Industrial de Santander in Colombia and his MS degree in Epidemiology from the Harvard School of Public Health, completing his residency in Clinical Pathology and his research fellowship training In immunology at the Harvard Medical School. His current research interests include immunogenicity to monoclonal antibody therapeutics and diagnostic immunology.

    Specialties

    • Pathology, Clinical

    Board Certification

    American Board of Histocompatibility
    American Board of Pathology (Clinical Path)

  • Dr. Delgado is the Executive Vice President at ARUP Laboratories, as well as Tenure Professor and Vice Chair, Department of Pathology at University of Utah. He is board certified in Clinical Pathology and Histocompatibility Laboratory testing by the American Board of Pathology and the American Board of Histocompatibility and Immunogenetics. He received his MD degree from Universidad Industrial de Santander in Colombia and his MS degree in Epidemiology from the Harvard School of Public Health, completing his residency in Clinical Pathology and his research fellowship training In immunology at the Harvard Medical School. His current research interests include immunogenicity to monoclonal antibody therapeutics and diagnostic immunology.

    Board Certification and Academic Information

    Academic Departments Pathology -Professor
    Board Certification
    American Board of Histocompatibility
    American Board of Pathology (Clinical Path)

    Education history

    Professional Medical Medicine - Universidad Industrial de Santander M.D.
    Postdoctoral Fellowship Immunogenetics - Dana-Farber Cancer Institute Postdoctoral Fellow
    Fellowship Pathology - Harvard Medical School Fellow
    Chief Resident Pathology - Brigham and Women's Hospital Chief Resident
    Postdoctoral Training Immunology Research - CBR Institute for Biomedical Research Postdoctoral Training
    Graduate Training Epidemiology - Harvard School of Public Health M.S.

    Selected Publications

    Journal Article

    1. Delgado, J.C., Greene, M.F., Winkelman, J.W., Tanasijevic, M.J. (2000). Comparison of disaturated phosphatidylcholine and fetal lung maturity surfactant/albumin ratio in diabetic and nondiabetic pregnancies. Am J Clin Pathol, 113(2), 233-9. (Read full publication)
    2. Genzen, J.R., Murray, D.L., Abel, G., Meng, Q.H., Baltaro, R.J., Rhoads, D.D., Delgado, J.C., Souers, R.J., Bashleben, C., Keren, D.F., Ansari, M.Q. (2018). Screening and Diagnosis of Monoclonal Gammopathies: An International Survey of Laboratory Practice. Arch Pathol Lab Med, 142(4), 507-515. (Read full publication)
    3. Nandakumar, V., Profaizer, T., Lozier, B.K., Elgort, M.G., Larragoite, E.T., Williams, E.S.C.P., Solis-Leal, A., Lopez, J.B., Berges, B.K., Planelles, V., Rychert, J., Slev, P.R., Delgado, J.C. (2021). Evaluation of a Surrogate Enzyme-Linked Immunosorbent Assay-Based Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) cPass Neutralization Antibody Detection Assay and Correlation With Immunoglobulin G Commercial Serology Assays. Arch Pathol Lab Med, 145(10), 1212-1220. (Read full publication)
    4. Stehlik, J., Islam, N., Hurst, D., Kfoury, A.G., Movsesian, M.A., Fuller, A., Delgado, J.C., Hammond, M.E., Gilbert, E.M., Renlund, D.G., Bader, F., Fisher, P.W., Bull, D.A., Singhal, A.K., Eckels, D.D. (2009). Utility of virtual crossmatch in sensitized patients awaiting heart transplantation. J Heart Lung Transplant, 28(11), 1129-34. (Read full publication)
    5. Ware, A.L., Malmberg, E., Delgado, J.C., Hammond, M.E., Miller, D.V., Stehlik, J., Kfoury, A., Revelo, M.P., Eckhauser, A., Everitt, M.D. (2016). The use of circulating donor specific antibody to predict biopsy diagnosis of antibody-mediated rejection and to provide prognostic value after heart transplantation in children. J Heart Lung Transplant, 35(2), 179-85. (Read full publication)
    6. Ko, B.S., Drakos, S., Kfoury, A.G., Hurst, D., Stoddard, G.J., Willis, C.A., Delgado, J.C., Hammond, E.H., Gilbert, E.M., Alharethi, R., Revelo, M.P., Nativi-Nicolau, J., Reid, B.B., McKellar, S.H., Wever-Pinzon, O., Miller, D.V., Eckels, D.D., Fang, J.C., Selzman, C.H., Stehlik, J., Utah Transplant Affiliated Hospitals (U.T.A.H.) Cardiac Transplant., P.r.o.g.r.a.m... (2016). Immunologic effects of continuous-flow left ventricular assist devices before and after heart transplant. J Heart Lung Transplant, 35(8), 1024-30. (Read full publication)
    7. Turbay, D., Lieberman, J., Alper, C.A., Delgado, J.C., Corzo, D., Yunis, J.J., Yunis, E.J. (1997). Tumor necrosis factor constellation polymorphism and clozapine-induced agranulocytosis in two different ethnic groups. Blood, 89(11), 4167-74. (Read full publication)
    8. Vonderheid EC, Pavlov I, Delgado JC, Martins TB, Telang GH, Hess AD, Kadin M (2014). Prognostic factors and risk stratification in early mycosis fungoides. Leukemia & lymphoma, 55(1), 44-50. (Read full publication)
    9. Weinreb S, Delgado JC, Clavijo OP, Yunis EJ, Bayer-Zwirello L, Polansky L, Deluhery L, Cohn G, Yao JT, Stec TC, Higby D, Anderzejewski (1998). Transplantation of unrelated cord blood cells. Bone marrow transplantation, 22(2), 193-6. (Read full publication)
    10. Cho HI, Reyes-Vargas E, Delgado JC, Celis (2012). A potent vaccination strategy that circumvents lymphodepletion for effective antitumor adoptive T-cell therapy. Cancer research, 72(8), 1986-95. (Read full publication)
    11. Lázár-Molnár E, Delgado J (2016). Immunogenicity Assessment of Tumor Necrosis Factor Antagonists in the Clinical Laboratory. Clinical chemistry, 62(9), 1186-98. (Read full publication)
    12. Lázár-Molnár E, Delgado J (2019). Implications of Monoclonal Antibody Therapeutics Use for Clinical Laboratory Testing. Clinical chemistry, 65(3), 393-405. (Read full publication)
    13. Rychert J, Delgado JC, Genzen J (2020). Modification of In Vitro Diagnostic Devices: Leveling the Playing Field. Clinical chemistry, 66(6), 760-762. (Read full publication)
    14. Pavlov IY, Wilson AR, Delgado J (2012). Reference interval computation: which method (not) to choose?. Clinica chimica acta; international journal of clinical chemistry, 413(13-14), 1107-14. (Read full publication)
    15. Pavlov IY, Delgado J (2013). Resampling model of the complement component functional assay: Are we measuring what we think we are measuring?. Clinica chimica acta; international journal of clinical chemistry, 421, 87-90. (Read full publication)
    16. Pavlov IY, Carper J, Lazar-Molnar E, Delgado J (2016). Clinical laboratory application of a reporter-gene assay for measurement of functional activity and neutralizing antibody response to infliximab. Clinica chimica acta; international journal of clinical chemistry, 453, 147-53. (Read full publication)
    17. Zhou Z, Reyes-Vargas E, Escobar H, Rudd B, Rockwood AL, Delgado JC, He X, Jensen P (2016). Type 1 diabetes associated HLA-DQ2 and DQ8 molecules are relatively resistant to HLA-DM mediated release of invariant chain-derived CLIP peptides. European journal of immunology, 46(4), 834-45. (Read full publication)
    18. Zhou Z, Reyes-Vargas E, Escobar H, Chang KY, Barker AP, Rockwood AL, Delgado JC, He X, Jensen P (2017). Peptidomic analysis of type 1 diabetes associated HLA-DQ molecules and the impact of HLA-DM on peptide repertoire editing. European journal of immunology, 47(2), 314-326. (Read full publication)
    19. Delgado JC, Eckels D (2008). Positive B-cell only flow cytometric crossmatch: implications for renal transplantation. Experimental and molecular pathology, 85(1), 59-63. (Read full publication)
    20. Mobini N, Yunis EJ, Alper CA, Yunis JJ, Delgado JC, Yunis DE, Firooz A, Dowlati Y, Bahar K, Gregersen PK, Ahmed A (1997). Identical MHC markers in non-Jewish Iranian and Ashkenazi Jewish patients with pemphigus vulgaris: possible common central Asian ancestral origin. Human immunology, 57(1), 62-7. (Read full publication)
    21. Delgado JC, Hameed A, Yunis JJ, Bhol K, Rojas AI, Rehman SB, Khan AA, Ahmad M, Alper CA, Ahmed AR, Yunis E (1997). Pemphigus vulgaris autoantibody response is linked to HLA-DQB1*0503 in Pakistani patients. Human immunology, 57(2), 110-9. (Read full publication)
    22. Wang S, Delgado JC, Ravkov E, Eckels DD, Georgelas A, Pavlov IY, Cusick M, Sebastian K, Gleich GJ, Wagner L (2012). Penaeus monodon tropomyosin induces CD4 T-cell proliferation in shrimp-allergic patients. Human immunology, 73(4), 426-31. (Read full publication)
    23. Ravkov EV, Pavlov IY, Martins TB, Gleich GJ, Wagner LA, Hill HR, Delgado J (2013). Identification and validation of shrimp-tropomyosin specific CD4 T cell epitopes. Human immunology, 74(12), 1542-9. (Read full publication)
    24. Profaizer T, Coonrod EM, Delgado JC, Kumanovics (2015). Report on the effects of fragment size, indexing, and read length on HLA sequencing on the Illumina MiSeq. Human immunology, 76(12), 897-902. (Read full publication)
    25. Profaizer T, Pole A, Monds C, Delgado JC, Lázár-Molnár (2020). Clinical utility of next generation sequencing based HLA typing for disease association and pharmacogenetic testing. Human immunology, 81(7), 354-360. (Read full publication)
    26. Delgado JC, Leung JY, Baena A, Clavijo OP, Vittinghoff E, Buchbinder S, Wolinsky S, Addo M, Walker BD, Yunis EJ, Goldfeld A (2003). The -1030/-862-linked TNF promoter single-nucleotide polymorphisms are associated with the inability to control HIV-1 viremia. Immunogenetics, 55(7), 497-501. (Read full publication)
    27. Delgado JC, Escobar H, Crockett DK, Reyes-Vargas E, Jensen P (2009). Identification of naturally processed ligands in the C57BL/6 mouse using large-scale mass spectrometric peptide sequencing and bioinformatics prediction. Immunogenetics, 61(3), 241-6. (Read full publication)
    28. Schultze JL, Michalak S, Seamon MJ, Dranoff G, Jung K, Daley J, Delgado JC, Gribben JG, Nadler L (1997). CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy. The Journal of clinical investigation, 100(11), 2757-65. (Read full publication)
    29. Boussiotis VA, Tsai EY, Yunis EJ, Thim S, Delgado JC, Dascher CC, Berezovskaya A, Rousset D, Reynes JM, Goldfeld A (2000). IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. The Journal of clinical investigation, 105(9), 1317-25. (Read full publication)
    30. Delgado JC, Baena A, Thim S, Goldfeld A (2006). Aspartic acid homozygosity at codon 57 of HLA-DQ beta is associated with susceptibility to pulmonary tuberculosis in Cambodia. Journal of immunology (Baltimore, Md., 176(2), 1090-7. (Read full publication)
    31. Escobar H, Crockett DK, Reyes-Vargas E, Baena A, Rockwood AL, Jensen PE, Delgado J (2008). Large scale mass spectrometric profiling of peptides eluted from HLA molecules reveals N-terminal-extended peptide motifs. Journal of immunology (Baltimore, Md., 181(7), 4874-82. (Read full publication)
    32. Chen LC, Delgado JC, Jensen PE, Chen (2009). Direct expansion of human allospecific FoxP3+CD4+ regulatory T cells with allogeneic B cells for therapeutic application. Journal of immunology (Baltimore, Md., 183(6), 4094-102. (Read full publication)
    33. Blanchard N, Kanaseki T, Escobar H, Delebecque F, Nagarajan NA, Reyes-Vargas E, Crockett DK, Raulet DH, Delgado JC, Shastri (2010). Endoplasmic reticulum aminopeptidase associated with antigen processing defines the composition and structure of MHC class I peptide repertoire in normal and virus-infected cells. Journal of immunology (Baltimore, Md., 184(6), 3033-42. (Read full publication)
    34. Kanaseki T, Lind KC, Escobar H, Nagarajan N, Reyes-Vargas E, Rudd B, Rockwood AL, Van Kaer L, Sato N, Delgado JC, Shastri (2013). ERAAP and tapasin independently edit the amino and carboxyl termini of MHC class I peptides. Journal of immunology (Baltimore, Md., 191(4), 1547-55. (Read full publication)
    35. Chen L, Reyes-Vargas E, Dai H, Escobar H, Rudd B, Fairbanks J, Ho A, Cusick MF, Kumánovics A, Delgado J, He X, Jensen P (2014). Expression of the mouse MHC class Ib H2-T11 gene product, a paralog of H2-T23 (Qa-1) with shared peptide-binding specificity. Journal of immunology (Baltimore, Md., 193(3), 1427-39. (Read full publication)
    36. Pavlov IY, Parker RL, Lázár-Molnár E, Strathmann FG, Delgado J (2019). Inductively coupled plasma mass spectrometry assay for quantification of free infliximab in serum. Journal of immunological methods, 470, 33-39. (Read full publication)
    37. Delgado JC, Baena A, Thim S, Goldfeld A (2002). Ethnic-specific genetic associations with pulmonary tuberculosis. The Journal of infectious diseases, 186(10), 1463-8. (Read full publication)
    38. Kadin ME, Pavlov IY, Delgado JC, Vonderheid E (2012). High soluble CD30, CD25, and IL-6 may identify patients with worse survival in CD30+ cutaneous lymphomas and early mycosis fungoides. The Journal of investigative dermatology, 132(3 Pt 1), 703-10. (Read full publication)
    39. Reyes-Vargas E, Pavlov IY, Martins TB, Schwartz JJ, Hill HR, Delgado J (2009). Binding of anti-HLA class I antibody to endothelial cells produce an inflammatory cytokine secretory pattern. Journal of clinical laboratory analysis, 23(3), 157-60. (Read full publication)
    40. Welch RJ, Merrigan SD, Delgado J (2012). A spectrophotometric method to precisely determine endpoint titers in complement fixation assays. Journal of clinical laboratory analysis, 26(3), 190-3. (Read full publication)
    41. Goldfeld AE, Delgado JC, Thim S, Bozon MV, Uglialoro AM, Turbay D, Cohen C, Yunis E (1998). Association of an HLA-DQ allele with clinical tuberculosis. JAMA, 279(3), 226-8. (Read full publication)
    42. Thim S, Sath S, Sina M, Tsai EY, Delgado JC, Shapiro AE, Barry CE 3rd, Glaziou P, Goldfeld A (2004). A community-based tuberculosis program in Cambodia. JAMA, 292(5), 566-8. (Read full publication)
    43. Delgado JC, Turbay D, Yunis EJ, Yunis JJ, Morton ED, Bhol K, Norman R, Alper CA, Good RA, Ahmed (1996). A common major histocompatibility complex class II allele HLA-DQB1* 0301 is present in clinical variants of pemphigoid. Proceedings of the National Academy of Sciences of the United States of America, 93(16), 8569-71. (Read full publication)
    44. Flores-Villanueva PO, Yunis EJ, Delgado JC, Vittinghoff E, Buchbinder S, Leung JY, Uglialoro AM, Clavijo OP, Rosenberg ES, Kalams SA, Braun JD, Boswell SL, Walker BD, Goldfeld A (2001). Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity. Proceedings of the National Academy of Sciences of the United States of America, 98(9), 5140-5. (Read full publication)
    45. Delgado JC, Tsai EY, Thim S, Baena A, Boussiotis VA, Reynes JM, Sath S, Grosjean P, Yunis EJ, Goldfeld A (2002). Antigen-specific and persistent tuberculin anergy in a cohort of pulmonary tuberculosis patients from rural Cambodia. Proceedings of the National Academy of Sciences of the United States of America, 99(11), 7576-81. (Read full publication)
    46. Bozón MV, Delgado JC, Turbay D, Salazar M, Granja CB, Alosco SM, Dupont B, Yunis E (1996). Comparison of HLA-A antigen typing by serology with two polymerase chain reaction based DNA typing methods: implications for proficiency testing. Tissue antigens, 47(6), 512-8. (Read full publication)
    47. Delgado JC, Yunis DE, Bozón MV, Salazar M, Deulofeut R, Turbay D, Mehra NK, Pasricha JS, Raval RS, Patel H, Shah BK, Bhol K, Alper CA, Ahmed AR, Yunis E (1996). MHC class II alleles and haplotypes in patients with pemphigus vulgaris from India. Tissue antigens, 48(6), 668-72. (Read full publication)
    48. Bozón MV, Delgado JC, Selvakumar A, Clavijo OP, Salazar M, Ohashi M, Alosco SM, Russell J, Yu N, Dupont B, Yunis E (1997). Error rate for HLA-B antigen assignment by serology: implications for proficiency testing and utilization of DNA-based typing methods. Tissue antigens, 50(4), 387-94. (Read full publication)
    49. Clavijo OP, Delgado JC, Awdeh ZL, Fici D, Turbay D, Alper CA, Truedsson L, Yunis E (1998). HLA-Cw alleles associated with HLA extended haplotypes and C2 deficiency. Tissue antigens, 52(3), 282-5. (Read full publication)
    50. Uglialoro AM, Turbay D, Pesavento PA, Delgado JC, McKenzie FE, Gribben JG, Hartl D, Yunis EJ, Goldfeld A (1998). Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-alpha gene promoter. Tissue antigens, 52(4), 359-67. (Read full publication)
    51. Clavijo OP, Delgado JC, Yu N, Fraser PA, Yunis E (1999). HLA-Cw*1701 is associated with two sub-Saharan African-derived HLA haplotypes: HLA-B*4201, DRB1*03 and HLA-B*4202 without DRB1*03. Tissue antigens, 54(3), 303-6. (Read full publication)
    52. Profaizer T, Eckels D, Delgado J (2011). Celiac disease and HLA typing using real-time PCR with melting curve analysis. Tissue antigens, 78(1), 31-7. (Read full publication)
    53. Husain Z, Almeciga I, Delgado JC, Clavijo OP, Castro JE, Belalcazar V, Pinto C, Zuniga J, Romero V, Yunis E (2006). Increased FasL expression correlates with apoptotic changes in granulocytes cultured with oxidized clozapine. Toxicology and applied pharmacology, 214(3), 326-34. (Read full publication)
    54. Heikal NM, Bader FM, Martins TB, Pavlov IY, Wilson AR, Barakat M, Stehlik J, Kfoury AG, Gilbert EM, Delgado JC, Hill H (2013). Immune function surveillance: association with rejection, infection and cardiac allograft vasculopathy. Transplantation proceedings, 45(1), 376-82. (Read full publication)
    55. Delgado JC, Fuller A, Ozawa M, Smith L, Terasaki PI, Shihab FS, Eckels D (2009). No occurrence of de novo HLA antibodies in patients with early corticosteroid withdrawal in a 5-year prospective randomized study. Transplantation, 87(4), 546-8. (Read full publication)
    56. Delgado JC, Pavlov IY, Shihab F (2009). Post-transplant increased levels of serum sCD30 is a marker for prediction of kidney allograft loss in a 5-year prospective study. Transplant immunology, 22(1-2), 1-4. (Read full publication)
    57. Samore MH, Looney A, Orleans B, Greene T, Seegert N, Delgado JC, Presson A, Zhang C, Ying J, Zhang Y, Shen J, Slev P, Gaulin M, Yang MJ, Pavia AT, Alder S (2021). Probability-Based Estimates of Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence and Detection Fraction, Utah, USA. Emerging infectious diseases, 27(11), 2786-2794. (Read full publication)
    58. Delgado JC, Quinones-Berrocal J, Thim S, Miranda LF, Goldfeld A (2004). Diagnostic and clinical implications of response to tuberculin in two ethnically distinct populations from Peru and Cambodia. The international journal of tuberculosis and lung disease, 8(8), 982-7. (Read full publication)
    59. Jacobs JFM, Turner KA, Graziani MS, Frinack JL, Ettore MW, Tate JR, Booth RA, McCudden CR, Keren DF, Delgado JC, Zemtsovskaja G, Fullinfaw RO, Caldini A, de Malmanche T, Katakouzinos K, Burke M, Palladini G, Altinier S, Zaninotto M, Righetti G, Melki MT, Bell S, Willrich MA (2020). An international multi-center serum protein electrophoresis accuracy and M-protein isotyping study. Part II: limit of detection and follow-up of patients with small M-proteins. Clinical chemistry and laboratory medicine, 58(4), 547-559. (Read full publication)
    60. Turner KA, Frinack JL, Ettore MW, Tate JR, Graziani MS, Jacobs JFM, Booth RA, McCudden CR, Keren DF, Delgado JC, Zemtsovskaja G, Fullinfaw RO, Caldini A, de Malmanche T, Katakouzinos K, Burke M, Palladini G, Altinier S, Zaninotto M, Righetti G, Melki MT, Bell S, Willrich MA (2020). An international multi-center serum protein electrophoresis accuracy and M-protein isotyping study. Part I: factors impacting limit of quantitation of serum protein electrophoresis. Clinical chemistry and laboratory medicine, 58(4), 533-546. (Read full publication)
    61. Baena A, Leung JY, Sullivan AD, Landires I, Vasquez-Luna N, Quinones-Berrocal J, Fraser PA, Uko GP, Delgado JC, Clavijo OP, Thim S, Meshnick SR, Nyirenda T, Yunis EJ, Goldfeld A (2002). TNF-alpha promoter single nucleotide polymorphisms are markers of human ancestry. Genes and immunity, 3(8), 482-7. (Read full publication)
    62. Pavlov IY, De Forest N, Delgado J (2011). Specificity of EIA immunoassay for complement factor Bb testing. Clinical laboratory, 57(3-4), 225-8. (Read full publication)
    63. Pavlov IY, Shihab F, Delgado J (2011). Urine TGF- beta1 assay validation: spinning down urine samples could diminish TGF-beta1 signal. Clinical laboratory, 57(11-12), 1027-9. (Read full publication)
    64. Delgado JC, Jensen P (2007). Trimming creates a new self-image. Nature immunology, 8(1), 21-2. (Read full publication)
    65. Kincaid EZ, Che JW, York I, Escobar H, Reyes-Vargas E, Delgado JC, Welsh RM, Karow ML, Murphy AJ, Valenzuela DM, Yancopoulos GD, Rock K (2011). Mice completely lacking immunoproteasomes show major changes in antigen presentation. Nature immunology, 13(2), 129-35. (Read full publication)
    66. Delgado JC, Jensen P (2008). Cat and mouse. Nature immunology, 9(8), 829-30. (Read full publication)
    67. Taborda NA, Cataño JC, Delgado JC, Rugeles MT, Montoya C (2012). Higher SLPI expression, lower immune activation, and increased frequency of immune cells in a cohort of Colombian HIV-1 controllers. Journal of acquired immune deficiency syndromes (1999), 60(1), 12-9. (Read full publication)
    68. Delgado JC, Shulman LN, Gudrais P, Fischer GA, Fergurson DO, Winkelman JW, Tanasijevic M (2001). Standardization of CEA testing in the setting of clinical laboratory consolidation. Laboratory medicine, (32), 92-5.
    69. Delgado JC, Loughlin KR, Bosch RJ, Tanasijevic M (2002). Comparison of the Tandem-E Immunoenzymetric and Immuno-1 PSA assays. Laboratory medicine, (33), 208-11.
    70. Escobar H, Reyes-Vargas E, Jensen PE, Delgado JC, Crockett D (2011). Utility of characteristic QTOF MS/MS fragmentation for MHC class I peptides. Journal of proteome research, 10(5), 2494-507. (Read full publication)
    71. Ravkov EV, Pavlov IY, Hanson KE, Delgado J (2012). Validation of cytomegalovirus immune competence assays for the characterization of CD8(+) T cell responses posttransplant. Clinical & developmental immunology, 2012, 451059. (Read full publication)
    72. Bedoya VI, Jaimes FA, Delgado JC, Rugeles C, Usuga X, Zapata W, Castaño ME, Boasso A, Shearer G, Rugeles M (2008). Fetal-maternal HLA-A and -B discordance is associated with placental RNase expression and anti-HIV-1 activity. Current HIV research, 6(4), 380-7. (Read full publication)
    73. Zheng Y, Larragoite ET, Williams ESCP, Lama J, Cisneros I, Delgado JC, Slev P, Rychert J, Innis EA, Coiras M, Rondina MT, Spivak AM, Planelles (2021). Neutralization assay with SARS-CoV-1 and SARS-CoV-2 spike pseudotyped murine leukemia virions. Virology journal, 18(1), 1. (Read full publication)
    74. Ravkov EV, Charlton CM, Barker AP, Hill H, Peterson LK, Slev P, Tebo A, Voelkerding KV, Wittwer CT, Heikal N, Delgado JC, Lázár-Molnár E, Kumánovics (2019). Evaluation of Mass Cytometry in the Clinical Laboratory. Cytometry. Part B, Clinical cytometry, 96(4), 266-274. (Read full publication)
    75. Profaizer T, Lazar-Molnar E, Pole A, Delgado JC, Kumanovics (2017). HLA genotyping using the Illumina HLA TruSight next-generation sequencing kits: A comparison. International journal of immunogenetics, 44(4), 164-168. (Read full publication)
    76. Pavlov I, Martins TB, Delgado J (2009). Development and validation of a fluorescent microsphere immunoassay for soluble CD30 testing. Clinical and vaccine immunology, 16(9), 1327-31. (Read full publication)
    77. Pavlov IY, Wilson AR, Delgado J (2010). Resampling approach for determination of the method for reference interval calculation in clinical laboratory practice. Clinical and vaccine immunology, 17(8), 1217-22. (Read full publication)
    78. Greene DN, Jackson ML, Hillyard DR, Delgado JC, Schmidt R (2020). Decreasing median age of COVID-19 cases in the United States-Changing epidemiology or changing surveillance?. PloS one, 15(10), e0240783. (Read full publication)
    79. Chiaro TR, Soto R, Zac Stephens W, Kubinak JL, Petersen C, Gogokhia L, Bell R, Delgado JC, Cox J, Voth W, Brown J, Stillman DJ, O'Connell RM, Tebo AE, Round J (2017). A member of the gut mycobiota modulates host purine metabolism exacerbating colitis in mice. Science translational medicine, 9(380), (Read full publication)
    80. Gundlapalli AV, Delgado JC, Jackson BR, Tricot GJ, Hill H (2009). Composite patient reports: a laboratory informatics perspective and pilot project for personalized medicine and translational research. Summit on translational bioinformatics, 2009, 39-43. (Read full publication)
    81. Cronin K, Escobar H, Szekeres K, Reyes-Vargas E, Rockwood AL, Lloyd MC, Delgado JC, Blanck (2013). Regulation of HLA-DR peptide occupancy by histone deacetylase inhibitors. Human vaccines & immunotherapeutics, 9(4), 784-9. (Read full publication)
    82. Acevedo-Sáenz L, Carmona-Pérez L, Velilla-Hernández PA, Delgado JC, Rugeles L M (2015). The APPEESFRS Peptide, Restricted by the HLA-B*35:01 Molecule, and the APPEESFRF Variant Derived from an Autologous HIV-1 Strain Induces Polyfunctional Responses in CD8+ T Cells. BioResearch open access, 4(1), 115-20. (Read full publication)
    83. Profaizer T, Lazar-Molnar E, Close DW, Delgado JC, Kumanovics (2016). HLA genotyping in the clinical laboratory: comparison of next-generation sequencing methods. HLA, 88(1-2), 14-24. (Read full publication)
    84. Delgado J (2019). Value of Urinary Free Light Chain Testing for Monitoring of Bence Jones Proteinuria. The journal of applied laboratory medicine, 3(6), 1059-1060. (Read full publication)
    85. Thoren KL, Pasi B, Delgado JC, Wu AHB, Lynch K (2018). Quantitation of Infliximab and Detection of Antidrug Antibodies in Serum by Use of Surface Plasmon Resonance. The journal of applied laboratory medicine, 2(5), 725-736. (Read full publication)
    86. Willrich MAV, Lazar-Molnar E, Snyder MR, Delgado J (2018). Comparison of Clinical Laboratory Assays for Measuring Serum Infliximab and Antibodies to Infliximab. The journal of applied laboratory medicine, 2(6), 893-903. (Read full publication)
    87. Rychert J, Couturier MR, Elgort M, Lozier BK, La'ulu S, Genzen JR, Straseski JA, Delgado JC, Slev P (2021). Evaluation of 3 SARS-CoV-2 IgG Antibody Assays and Correlation with Neutralizing Antibodies. The journal of applied laboratory medicine, 6(3), 614-624. (Read full publication)
    88. Nelson HA, Genzen JR, Delgado JC, Rudolf J (2021). An Interference in an Automated HCO3- Assay Leads to an Unexpected IgG Monoclonal Gammopathy Diagnosis. The journal of applied laboratory medicine, 7, 622-625. (Read full publication)
    89. Nandakumar V, Profaizer T, Lozier BK, Elgort MG, Rychert J, Slev PR, Delgado J (2021). Evaluation of a Novel Multiplex Platform for Simultaneous Detection of IgG Antibodies against the Four Main SARS-CoV-2 Antigens. The journal of applied laboratory medicine, 7(3), 698-710. (Read full publication)
    90. Profaizer T, Dibb K, Bethers H, Monds C, Andreasen J, Delgado JC, Lázár-Molnár (2021). Comparison of Next-Generation Sequencing-Based Human Leukocyte Antigen Typing with Clinical Flow Cytometry and Allele-Specific PCR Melting Assays for HLA-B27 Genotyping. The journal of applied laboratory medicine, 6(5), 1221-1227. (Read full publication)
    91. Hartsell JD, Leung DT, Zhang Y, Delgado JC, Alder SC, Samore M (2023). Sex difference in the discordance between Abbott Architect and EuroImmun serological assays. PeerJ, 11, e15247. (Read full publication)
    92. Kim SJ, Yao Z, Marsh MC, Eckert DM, Kay MS, Lyakisheva A, Pasic M, Bansal A, Birnboim C, Jha P, Galipeau Y, Langlois MA, Delgado JC, Elgort MG, Campbell RA, Middleton EA, Stagljar I, Owen S (2022). Homogeneous surrogate virus neutralization assay to rapidly assess neutralization activity of anti-SARS-CoV-2 antibodies. Nature communications, 13(1), 3716. (Read full publication)
    93. Jain D, Pido MTJ, Delgado JC, Willrich MAV, Lázár-Molnár (2023). Comparison of Two Clinical Laboratory Assays for Measuring Serum Adalimumab and Antibodies to Adalimumab. The journal of applied laboratory medicine, 8(6), 1054-1064. (Read full publication)
    94. Ravkov EV, Williams ESCP, Elgort M, Barker AP, Planelles V, Spivak AM, Delgado JC, Lin L, Hanley T (2024). Reduced monocyte proportions and responsiveness in convalescent COVID-19 patients. Frontiers in immunology, 14, 1329026. (Read full publication)
    95. Ravkov EV, Ventura MF, Gudipaty S, Ng D, Delgado JC, Lin (2024). Converting an HLA-B27 flow assay from the BD FACSCanto to the BD FACSLyric. Cytometry. Part B, Clinical cytometry, 108(1), 67-76. (Read full publication)
    96. Pandya V, Delgado J (2025). Hiding in Plain Sight: Protein Electrophoresis Profile Inconsistent with Patient's Diagnosis. Clinical chemistry, 71(2), 248-252. (Read full publication)
    97. Peterson LK, Nandakumar V, Valentine JF, Delgado JC, Saadalla A (2025). The Utility of the Immunoglobulin A Flag Used in Celiac Disease Serology Testing on a Particle-Based Multianalyte Technology Platform. Clinical chemistry, 71(7), 818-820. (Read full publication)
    98. Profaizer T, Elgort MG, Delgado J (2025). Development and laboratory validation of an electrochemiluminescence ELISA technique for measuring infliximab concentrations and anti-drug antibodies. Journal of immunological methods, 540, 113865. (Read full publication)
    99. Jain D, Pavlov IY, ¿u'nik S, Delgado JC, Lázár-Molnár (2025). Expanding the clinical utility of reporter gene assay to infliximab biosimilars. Clinica chimica acta; international journal of clinical chemistry, 575, 120337. (Read full publication)
    100. Ravkov EV, Williams ESCP, Elgort M, Barker AP, Planelles V, Spivak AM, Delgado JC, Lin L, Hanley T (2023). Reduced Monocyte Proportions and Responsiveness in Convalescent COVID-19 Patients. bioRxiv, (Read full publication)
    101. Delgado ID, Delgado JC, Burns R (2025). The Effect of High-Intensity Interval Training on Visceral Adipose Tissue in Type 2 Diabetes: A Systematic Review. Int J Exerc Sci, 18(5), 1321-1333.

    Book Chapter

    1. Delgado JC, Yunis E (2007). The Major Histocompatibility Complex and Disease. 894-905.
    2. Delgado JC, Yunis E (2001). The Major Histocompatibility Complex and Disease. 949-62.
    3. Hors J, ElChenawi F, Djoulah S, Hafez M, Abbas F, ElBorai MH, Kamel M, Abbal M, Cambon-Thomsen A, Mercier P, Reviron D, Magzoub MA, Rosner G, Delgado JC, Yunis EJ, Raffoux C, Tamouza R, Izaabel H, Hmida S, Benhamamouch S, Bessaoud K, Langaney A, Sanchez-Mazas (1998). HLA in North African populations: 12th International Histocompatibility Workshop NAFR report. 328-34.
    4. Delgado JC, Sese DE, Milford EL, Yunis E (2001). Analysis of HLA class II DRB1 alleles using PCR-RFLP.
    5. Delgado J (2011). The Major Histocompatibility Complex and Disease. 954-962.
    6. Kumanovics A, Delgado J (2016). The Major Histocompatibility Complex and Disease. 973-982.
    7. Genzen JR, Peake R, Tate J, Delgado JC, Miller (2017). Tietz Atlas of Electrophoretic Patterns.
    8. Lazar-Molnar E, Willrich MAV, Delgado J (2022). Monoclonal Antibody Therapeutics and Immunogenicity.

    Editorial

    1. Delgado JC, Lázár-Molnár (2018). HLA in Transplantation and Beyond. Clinics in laboratory medicine, 38(4), xi-xii. (Read full publication)

    Other

    1. Delgado JC, Yunis E (1997). Stem Cell transplatation: Medical and technical aspects.

    Video/Film/CD/Web/Podcast

    1. Delgado J (2015). Spotlight on Testing: High-Resolution HLA Genotyping by Next-Generation Sequencing.
    2. Delgado J (2014). Spotlight on Testing: Test-Guided Management of Treatment Failure to TNF-alpha Antagonists.

  • News & Podcasts

    News